Start the topMIND proof-of-concept trial of tafasitamab plus parsaclisib

No public evidence found either way

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced: 4 May 2021
Due: 31 Dec 2021
Last checked: 10 Oct 2026

Deadline
Met
Late
Not met
Today

What the company said

“A proof-of-concept trial evaluating tafasitamab plus parsaclisib (topMIND) is expected to start later this year”

SourceIncyte Form 8-K press release, 2021-05-04
FilingSEC filing index
Deadline as statedlater this year
Deadline used31 Dec 2021, the last day of the stated period
TypeProject
Permanent referenceKI-C-2021-INCY-005682
Cite as https://keptindex.org/c/KI-C-2021-INCY-005682/ — this address never changes.

What we found

After 4 checks we found no clear public record either way, so this commitment is not counted as met or not met.

If you have a public source showing the outcome, please send it to us.

Commitment lineage

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

Deadline drift +34 days
2 versions

Version 1 · original · stated 4 May 2021

Deadline 31 Dec 2021 (“later this year”) · wording expected
Version 2 · stated 3 Aug 2021

Deadline 3 Feb 2022 (“in the next six months”) · wording expected

“An additional proof of concept trial (coreMIND) of tafasitamab in combination with parsaclisib for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL) is expected to start in the next six months.”
Source for this version

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Clinical milestone
Indicative materiality: Medium rules
Action: Start
Deliverable: topMIND proof-of-concept trial of tafasitamab plus parsaclisib
Language: Expected (“expects”, “plans”)
In the company’s control: Medium
Specificity: High
Depends on: Partner

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Incyte? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.